Device Trial Radar · NCT05442203
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
Last checked: Nov 20, 2026Latest source record: Jul 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,000
Planned (sponsor's estimate)
Start
Sep 7, 2022
Primary completion
Jul 2025
Study completion Jul 2025
Sponsor
- Lead sponsor
- Tempus AINot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 1, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural heart disease and do not know it. The purpose of this study is to evaluate two devices that can predict who has or may develop atrial fibrillation or structural heart disease based on the results of an electrocardiogram.
Conditions
- Atrial Fibrillation
- Structural Heart Disease
Interventions
Zio Patch MonitorDevice
Patch monitor will be applied and worn for a 2-week period at baseline, month 6, and month 12 after assignment to the AF arm.
EchocardiogramDevice
Ultrasound study of the heart will be completed upon patient consent after assignment to the SHD arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive-predictive value (PPV) of the AF device at six monthsTime frame: 12 months
- Positive-predictive value (PPV) of the SHD device at six monthsTime frame: 12 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Corewell Health
Grand Rapids, Michigan
TriHealth
Cincinnati, Ohio
Geisinger Medical Center
Danville, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.